Last updated: August 24, 2022
Sponsor: Shanghai Chest Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
Pulmonary Nodules
Treatment
N/AClinical Study ID
NCT05512533
SHCHE202208
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients older than 18 years old.
- Chest imaging shows the presence of peripheral pulmonary lesions (surrounded bypulmonary parenchyma and located below the segmental bronchus/located at least 2airway generations from the main carina as seen radiographically.) suspicious ofmalignancy, 0.8-5cm in greatest diameter in need of bronchoscopic biopsy for clinicalpurposes, and the investigators consider it possible to be biopsied with BF-UC290F (the bronchus adjacent or leading to the PPLs are ≥5mm in diameter, thus BF-UC290F isable to arrival/access).
- Patients without contraindications of bronchoscopy.
- Patients have good medical adherence and signed informed consent.
Exclusion
Exclusion Criteria:
- Peripheral pulmonary lesion is pure ground-glass opacity.
- Visible lumen lesions during bronchoscopy
- The lesions were adjacent to the central airway (trachea, left and right mainbronchus, and right middle bronchus), and the biopsies by the Thin Convex Probe EBUSScope BF-UC290F were conducted without leaf bronchus entry
- The investigators believe that patient has other conditions that are not suitable forthe study.
Study Design
Total Participants: 30
Study Start date:
August 22, 2022
Estimated Completion Date:
October 31, 2023
Study Description
Connect with a study center
Shanghai Chest Hospital
Shanghai, Shanghai 200030
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.